Phone-based telemedicine support for quality of life in chronic heart failure
Tests phone calls and text messages as support for adults with chronic heart failure.
Plain-language title generated from the registry record
Registry title: Mobile-Based Telemedicine and Health-Related Quality of Life Among Patients With Chronic Heart Failure (MOBILE-HF)
Key facts
- Where
- Addis Ababa, EthiopiaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-65 with long-lasting heart failure and a weak heart pump. They need a mobile phone.
- Age
- 18 to 65 years
- Sex
- All sexes can join.
- Disease stage
- Chronic heart failure for 6 months or more, NYHA class II-III, with left ventricular ejection fraction (LVEF) of 40% or less, confirmed by echocardiography and clinical assessment.
- Biomarker or test result
- Left ventricular ejection fraction (LVEF) of 40% or less.
Main reasons for not taking part
- NYHA class IV or needing intensive care at enrollment
- Other severe illness, such as end-stage kidney disease or end-stage liver disease
- Severe cognitive impairment or psychiatric illness that would get in the way of taking part
- Already in another telemedicine or intervention study
- Pregnant or breastfeeding women
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07650474, who can take part
Where in Ethiopia
- Menelik II Comprehensive Specialized HospitalAddis Ababa, EthiopiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Select College
- Trial code
- NCT07650474
- Record updated
- 17 June 2026
- Original description
Chronic heart failure (CHF) is a long-term condition in which the heart is unable to pump blood effectively. It can cause symptoms such as shortness of breath, fatigue, swelling in the legs, and reduced ability to perform daily activities. These problems often reduce a patient's quality of life and may lead to frequent hospital visits.Read full original descriptionShow less
Effectiveness of Mobile-Based Telemedicine on Health-Related Quality of Life Among Patients With Chronic Heart Failure: Protocol for a Quasi-Experimental Study
Chronic heart failure (CHF) is a long-term condition in which the heart is unable to pump blood effectively. It can cause symptoms such as shortness of breath, fatigue, swelling in the legs, and reduced ability to perform daily activities. These problems often reduce a patient's quality of life and may lead to frequent hospital visits.
This study will assess whether a mobile-based telemedicine program can improve the health-related quality of life of patients with chronic heart failure in Ethiopia.
In this study, 70 adult patients with chronic heart failure will be included. They will be divided into two groups: 35 patients will receive routine care plus mobile-based telemedicine support, and 35 patients will receive routine care only.
The mobile-based telemedicine program will include health education, medication reminders, lifestyle advice, and follow-up support delivered through phone calls and text messages over an 8-week period.
Patients' quality of life will be measured at the beginning of the study and again after 8 weeks using a standard questionnaire called the Minnesota Living with Heart Failure Questionnaire (MLHFQ).
The main goal of the study is to determine whether mobile-based telemedicine improves quality of life compared with routine care alone. The study may also help improve self-care behaviors, medication adherence, and symptom control among patients with heart failure.
The findings may provide evidence to support the use of mobile health technologies as a simple and scalable approach to improve heart failure care in Ethiopia.
Inclusion: Adults aged 18-65 years who will be diagnosed with CHF (NYHA class II⁃III); Patients with reduced left ventricular ejection fraction LVEF ≤ 40%; Patient who will have access to a mobile phone and will be able to use it; Patients who will be able to communicate in Amharic, Oromic, or English; Patients who will provide written informed consent; Patients who will be diagnosed with HF lasting ≥ 6 months, to be confirmed by echocardiography and clinical assessment; Patients with no contraindications for mild to moderate physical activity.
Exclusion: Patients with other severe medical conditions (e.g., end-stage renal disease, \& end stage liver disease); Patients with severe cognitive impairment or psychiatric illness that will interfere with participation; Patients with NYHA class IV or who will require intensive care at enrollment; Patients already enrolled in another telemedicine or intervention study; Pregnant and lactating women.